Premium
Juvenile psoriatic arthritis carrying familial Mediterranean fever gene mutations in a 14‐year‐old Turkish girl
Author(s) -
YENIAY Betul Sozeri,
KARACA Neslihan Edeer,
YUKSEL Seciye Eda,
MIDYAT Levent,
KUTUKCULER Necil
Publication year - 2007
Publication title -
the journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.9
H-Index - 65
eISSN - 1346-8138
pISSN - 0385-2407
DOI - 10.1111/j.1346-8138.2007.00285.x
Subject(s) - familial mediterranean fever , medicine , mefv , dactylitis , psoriatic arthritis , arthritis , dermatology , sacroiliitis , sulfasalazine , gene mutation , immunology , enthesitis , disease , mutation , genetics , ulcerative colitis , gene , biology
Juvenile psoriatic arthritis (JPsA) is characterized by asymmetric arthritis of big and small joints, enthesitis, dactylitis, psoriatic skin lesions and nail pitting. Investigators agree that JPsA is a relatively common chronic arthropathy of childhood that differs clinically, serologically, and genetically from both juvenile idiopathic arthritis and juvenile ankylosing spondylitis. Familial Mediterranean fever (FMF) is a multisystemic autosomal recessive disease occasionally accompanied by sacroiliitis. This is characterized by recurrent self‐limited attacks of fever and accompanying abdominal, chest and arthricular pain. We present a 14‐year‐old Turkish girl with JPsA and carrying FMF gene mutations. In this patient, JPsA was diagnosed according to her physical, laboratory and skin biopsy findings and a treatment with methotrexate and sulfasalazine was started. As an inadequate clinical and laboratory response was obtained after the first month of therapy, the patient was investigated for FMF, and was diagnosed by molecular analyses of related gene (E148Q heterozygous/V726A homozygous mutation) besides clinical findings. After 2 weeks of the colchicine treatment, symptoms of the patient regressed and acute phase reactants decreased. To our knowledge, this is the first case presenting with psoriatic arthritis and FMF gene mutations together and responds to colchicine, methotrexate and sulfasalazine dramatically in clinical and laboratory findings. This case has been presented to remind that cases with psoriatic arthritis may also carry mutations in the MEFV gene.